Joseph P Connor Selected Research

Fc(alpha) receptor

1/2022	Anti-SARS-CoV-2 IgG and IgA antibodies in COVID-19 convalescent plasma do not enhance viral infection.
9/2021	Anti-SARS-CoV-2 IgG and IgA antibodies in COVID-19 convalescent plasma do not facilitate antibody-dependent enhance of viral infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joseph P Connor Research Topics

Disease

13	Neoplasms (Cancer) 11/2018 - 05/2004
6	COVID-19 01/2022 - 10/2020
6	Ovarian Neoplasms (Ovarian Cancer) 05/2012 - 05/2004
5	Ovarian Epithelial Carcinoma 11/2018 - 05/2004
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 09/2012 - 12/2003
2	Infections 01/2022 - 09/2021
2	Virus Diseases (Viral Diseases) 01/2022 - 09/2021
2	Neoplasm Metastasis (Metastasis) 01/2011 - 01/2010
2	Ascites 11/2008 - 05/2004
1	Surgical Blood Loss 11/2018
1	Anemia 11/2018
1	Hepatocellular Carcinoma (Hepatoma) 12/2017
1	Hypophosphatemia 01/2013
1	Hypotension (Low Blood Pressure) 01/2013
1	Hemorrhage 09/2012
1	Leiomyosarcoma 07/2012
1	Pre-Eclampsia (Preeclampsia) 07/2012
1	Ureteral Obstruction 04/2012
1	Thrombocytopenia (Thrombopenia) 11/2008
1	Adenocarcinoma 09/2008
1	Hypersensitivity (Allergy) 05/2007
1	Carcinosarcoma 10/2006
1	Disease Progression 10/2006
1	Sarcoma (Soft Tissue Sarcoma) 10/2006
1	Pain (Aches) 08/2005
1	Flatulence 08/2005
1	Wounds and Injuries (Trauma) 08/2005
1	Atypical Squamous Cells of the Cervix 02/2002

Drug/Important Bio-Agent (IBA)

4	Monoclonal AntibodiesIBA 01/2022 - 01/2011
4	Biomarkers (Surrogate Marker)IBA 12/2017 - 12/2003
3	MucinsIBA 07/2012 - 01/2010
3	PlatinumIBA 05/2012 - 05/2007
2	Fc(alpha) receptorIBA 01/2022 - 09/2021
2	Fc gamma receptor IIAIBA 01/2022 - 09/2021
2	Immunoglobulin M (IgM)IBA 01/2022 - 09/2021
2	Protein SIBA 01/2022 - 09/2021
2	Immunoglobulin G (IgG)IBA 01/2022 - 09/2021
2	Immunoglobulin A (IgA)IBA 01/2022 - 09/2021
2	AntibodiesIBA 01/2022 - 09/2021
2	VaccinesIBA 01/2022 - 09/2021
2	Virus ReceptorsIBA 01/2022 - 09/2021
2	Epithelial Cell Adhesion MoleculeIBA 01/2013 - 05/2004
2	tucotuzumab celmoleukinIBA 01/2013 - 05/2004
2	Proteins (Proteins, Gene)FDA Link 01/2011 - 12/2003
2	ChromiumIBA 11/2008 - 05/2004
1	Viral RNAIBA 10/2020
1	Aldo-Keto ReductasesIBA 12/2017
1	CreatinineIBA 01/2013
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2013
1	Interleukin-2 (IL2)IBA 07/2012
1	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 05/2012
1	LigandsIBA 01/2012
1	AutoantibodiesIBA 01/2012
1	Glycoproteins (Glycoprotein)IBA 01/2012
1	GlycoconjugatesIBA 01/2012
1	CytokinesIBA 01/2012
1	Polysaccharides (Glycans)IBA 01/2012
1	ChemokinesIBA 01/2012
1	MesothelinIBA 01/2011
1	Peptides (Polypeptides)IBA 01/2011
1	EpitopesIBA 01/2011
1	AntigensIBA 01/2011
1	Tumor Biomarkers (Tumor Markers)IBA 01/2010
1	Heparin (Liquaemin)FDA LinkGeneric 11/2008
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 11/2008
1	AnticoagulantsIBA 11/2008
1	Fas Ligand Protein (Fas Ligand)IBA 11/2008
1	taxaneIBA 05/2007
1	Docetaxel (Taxotere)FDA Link 05/2007
1	Carboplatin (JM8)FDA LinkGeneric 05/2007
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 10/2006
1	Bupivacaine (Bupivacaine Hydrochloride)FDA LinkGeneric 08/2005
1	Therapeutic UsesIBA 05/2004
1	Cyclin EIBA 12/2003
1	Estrogens (Estrogen)FDA Link 12/2003
1	Metronidazole (Metric)FDA LinkGeneric 02/2002

Therapy/Procedure

8	Therapeutics 01/2022 - 05/2004
2	Immunotherapy 07/2012 - 05/2004
2	Drug Therapy (Chemotherapy) 03/2010 - 05/2007
2	Laparotomy 09/2008 - 08/2005
1	Blood Transfusion (Blood Transfusions) 11/2018
1	Neoadjuvant Therapy 11/2018
1	Autologous Blood Transfusion 09/2012
1	Hysterectomy 09/2012
1	Ostomy 04/2012
1	Lasers (Laser) 05/2007
1	Length of Stay 08/2005
1	Cytoreduction Surgical Procedures 05/2004